We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
- Authors
Victor, Teresa A.; Furey, Maura L.; Fromm, Stephen J.; Öhman, Arne; Drevets, Wayne C.
- Abstract
An emerging hypothesis regarding the mechanisms underlying antidepressant pharmacotherapy suggests that these agents benefit depressed patients by reversing negative emotional processing biases (Harmer, 2008). Neuropsychological indices and functional neuroimaging measures of the amygdala response show that antidepressant drugs shift implicit and explicit processing biases away from the negative valence and toward the positive valence. However, few studies have explored such biases in regions extensively connected with the amygdala, such as the pregenual anterior cingulate cortex (pgACC) area, where pre-treatment activity consistently has predicted clinical outcome during antidepressant treatment. We used functional magnetic resonance imaging (fMRI) to investigate changes in haemodynamic response patterns to positive vs. negative stimuli in patients with major depressive disorder (MDD) under antidepressant treatment. Participants with MDD (n = 10) underwent fMRI before and after 8 wk sertraline treatment; healthy controls (n = 10) were imaged across an equivalent interval. A backward masking task was used to elicit non-conscious neural responses to sad, happy and neutral face expressions. Haemodynamic responses to emotional face stimuli were compared between conditions and groups in the pgACC. The response to masked-sad vs. masked-happy faces (SN-HN) in pgACC in the depressed subjects was higher in the pre-treatment condition than in the post-treatment condition and this difference was significantly greater than the corresponding change across time in the controls. The treatment-associated difference was attributable to an attenuated response to sad faces and an enhanced response to happy faces. Pre-treatment pgACC responses to SN-HN correlated positively with clinical improvement during treatment. The pgACC participates with the amygdala in processing the salience of emotional stimuli. Treatment-associated functional changes in this limbic network may influence the non-conscious processing of such stimuli by reversing the negative processing bias extant in MDD.
- Subjects
ANTIDEPRESSANTS; EMOTIONS; MENTAL depression; THERAPEUTICS; BIOLOGICAL neural networks; DRUG therapy; NEUROPSYCHOLOGY; BRAIN imaging
- Publication
International Journal of Neuropsychopharmacology, 2013, Vol 16, Issue 10, p2195
- ISSN
1461-1457
- Publication type
Article
- DOI
10.1017/S146114571300062X